Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: Amarin Corporation plc

Market Cap 336M 293M 271M 254M 477M 31.72B 479M 3.22B 1.25B 15.61B 1.26B 1.23B 54.21B P/E 2026 *
-458x
P/E 2027 * 291x
Enterprise Value 162M 141M 131M 123M 230M 15.31B 231M 1.55B 602M 7.54B 609M 596M 26.17B EV / Sales 2026 *
0.89x
EV / Sales 2027 * 0.77x
Free-Float
89.38%
Yield 2026 *
-
Yield 2027 * -
1 day+1.65%
1 week+5.18%
Current month+10.63%
1 month+10.17%
3 months+10.63%
6 months+16.16%
Current year+14.87%
1 week 15
Extreme 15
16.3
1 month 13.6
Extreme 13.6
16.3
Current year 12.96
Extreme 12.96
17.31
1 year 12.3
Extreme 12.3
20.9
3 years 7.08
Extreme 7.08
29.7
5 years 7.08
Extreme 7.08
119.4
10 years 7.08
Extreme 7.08
522.4
Manager TitleAgeSince
Chief Executive Officer 63 04/06/2024
Director of Finance/CFO 42 23/10/2024
Compliance Officer 56 15/11/2023
Director TitleAgeSince
Director/Board Member 63 04/06/2024
Director/Board Member 47 28/02/2023
Chairman 51 27/03/2023
Date Insider Type Main position Quantity % Market Cap.
04-18Fiscal year

Chairman

2,079 0.0005%
04-18Fiscal year

Director

2,079 0.0005%
04-18Fiscal year

Director

2,079 0.0005%
Change 5-day change 1-year change 3-year change Capi.($)
+1.65%+5.18%+27.83%-31.50% 336M
+2.87%+4.57%+70.82%+119.22% 55.19B
+4.60%+3.02%+57.38%+62.27% 45.75B
-1.44%+0.39%-14.68%-15.42% 22.98B
-2.69%-2.10%-6.70%+363.03% 20.76B
-0.26%-0.58%+25.47%-18.57% 16.26B
-0.50%+2.29%+20.51%-37.38% 15.42B
-1.01%-2.30%+28.59%+173.07% 13.05B
+4.95%+11.70%+125.78%+261.94% 12.45B
-5.63%-6.39%+19.78% - 12.37B
Average +0.25%+2.81%+35.48%+97.41% 21.46B
Weighted average by Cap. +1.15%+1.52%+41.85%+105.06%

Financials

2026 *2027 *
Net sales 182M 159M 147M 138M 258M 17.2B 260M 1.75B 677M 8.46B 684M 669M 29.39B 193M 168M 156M 146M 273M 18.2B 275M 1.85B 716M 8.96B 724M 709M 31.11B
Net income -15.02M -13.1M -12.13M -11.36M -21.3M -1.42B -21.43M -144M -55.78M -698M -56.39M -55.18M -2.42B 22.13M 19.3M 17.87M 16.73M 31.38M 2.09B 31.57M 212M 82.17M 1.03B 83.07M 81.29M 3.57B
Net Debt -174M -152M -140M -131M -246M -16.41B -248M -1.67B -646M -8.08B -653M -639M -28.04B -187M -163M -151M -142M -266M -17.69B -267M -1.8B -696M -8.71B -704M -689M -30.24B
Logo Amarin Corporation plc
Amarin Corporation PLC is a pharmaceutical company. The Company is focused on the commercialization and development of therapeutics to improve cardiovascular (CV), health and reduce CV risk. The Company operates through the development and commercialization of VASCEPA. Its lead product, Vascepa (icosapent ethyl) capsule is used as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. This indication for Vascepa, known as the MARINE indication, is based primarily on the results from the MARINE study of Vascepa in this approved patient population. The Company sells Vascepa principally to wholesalers, as well as selected regional wholesalers and specialty pharmacy providers, or collectively, its distributors, which in turn resell Vascepa to retail pharmacies for resale to patients and healthcare providers.
Employees
80
Date Price Change Volume
18/06/26 16.03 $ +1.65% 87,091
17/06/26 15.77 $ +3.96% 81,442
16/06/26 15.17 $ -1.17% 106,362
15/06/26 15.35 $ +0.72% 97,590
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
2
Last Close Price
16.03USD
Average target price
12.50USD
Spread / Average Target
-22.02%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AMRN Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!